First, you have the accelerated degradation of the benzyl alcohol
Furthermore, phase 2 clinical trials were conducted on models of stasis and pressure ulcers
Most of what's "known" comes from: Preclinical work (animal/cell) exploring repair pathways, inflammation signaling, and vascular changes Limited human observations focused more on recovery and discomfort than on body fat change So, when someone searches for BPC 157 weight loss , it's essential to set expectations: this isn't like clinically validated obesity therapies that have decades of outcome data, standardized dosing, and predictable effects on appetite and metabolic pathwayssuch as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)
Most patients experience minimal discomfort during a liquid facelift
Choosing the wrong one can affect compound stability, shelf life, and the integrity of your reconstituted solution
And I would say fitness is probably my biggest hobby outside of medicine